根据一份提交给美国证券交易委员会（SEC）的文件，Aytu BioScience, Inc. 计划继续销售其现有的Metadate产品库存。该公司将在销售期间持续支付相应的特许权使用费，直至所有库存售罄为止。这一安排明确了该公司对该产品线剩余库存的处理方式及相关的财务义务。
根据一份提交给美国证券交易委员会（SEC）的文件，Aytu BioScience, Inc. 计划继续销售其现有的Metadate产品库存。该公司将在销售期间持续支付相应的特许权使用费，直至所有库存售罄为止。这一安排明确了该公司对该产品线剩余库存的处理方式及相关的财务义务。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.